Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Take anaesthesia of paediatric and geriatric patients seriously
Louise O'Dwyer.

Every patient is an individual – especially if they are very young or very old

"It is very easy to forget just how old some of our geriatric patients are, especially those coming in for routine operations, such as 'dentals'", said Louise O'Dwyer speaking at the BVNA Congress on the subject of 'The age divide – anaesthesia of geriatrics and paediatrics'. "Some of these patients actually present very high anaesthetic risks."

Louise encouraged delegates to remember that "every patient is an individual" and there are particular issues associated with organ changes at both ends of the age spectrum – immaturity in paediatric patients and degrees of failure in geriatrics. These factors have a significant influence on the effects and choice of premedication and anaesthetic agents.

There are physiological changes in the lungs of geriatric patients, including decreased functional residual volume, increased lung fibrosis and some respiratory muscular degeneration; and there is an increasing incidence of ischaemic changes to the brain resulting in cognitive dysfunction, blindness and loss of learned behaviour following anaesthesia.

Cardiac, hepatic and renal function is different from normal healthy individuals; and thermoregulation is likely to be compromised too.

Louise emphasised how important it was for nurses to pay detailed attention to the restraint and positioning of both paediatric and geriatric patients because of age-related muscular skeletal factors, not only during the course of the operative procedure but also throughout the recovery phase. There is a greater need for analgesics in geriatric patients.

She impressed upon delegates how nurses had a responsibility for assessing paediatric and geriatric patients well before induction and maintenance of anaesthesia. They will all have individual idiosyncrasies associated with their age and these must be taken into consideration by the whole team involved with premedication and the operative procedure.

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.